-
Impact of Extrapolation Model Choices on the Structural Uncertainty in Economic Evaluations for Cancer Immunotherapy: A Case Study of Checkmate 067
Author: Shao, Taihang; Zhao, Mingye; Liang, Leyi; Shi, Lizheng; Tang, Wenxi
Journal: PHARMACOECONOMICS-OPEN. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s41669-023-00391-5
-
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer
Author: Verhoek, Andre; Cheema, Parneet; Melosky, Barbara; Samson, Benoit; Shepherd, Frances A.; de Marinis, Filippo; John, Thomas; Wu, Yi-Long; Heeg, Bart; Van Dalfsen, Nadia; Bracke, Benjamin; Miranda, Miguel; Shaw, Simon; Moldaver, Daniel
Journal: PHARMACOECONOMICS-OPEN. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s41669-023-00396-0
-
Economic Evaluation of Nivolumab Versus Docetaxel for the Treatment of Advanced Squamous and Non-squamous Non-small Cell Lung Cancer After Prior Chemotherapy in China
Author: Hu, Shanlian; Tang, Zhiliu; Harrison, James P.; Hertel, Nadine; Penrod, John R.; May, Jessica R.; Juarez-Garcia, Ariadna; Holdgate, Orban
Journal: PHARMACOECONOMICS-OPEN. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s41669-022-00383-x